GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Core EBITDA Margin History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Core EBITDA Margin(%) | 31.01 | 28.56 | 24.01 | 22.54 | 21.20 |
What is the latest Core EBITDA Margin ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Core EBITDA Margin |
|---|---|
| Mar2026 | 31.01 |
| Mar2025 | 28.56 |
| Mar2024 | 24.01 |
| Mar2023 | 22.54 |
| Mar2022 | 21.20 |
How is Core EBITDA Margin of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Core EBITDA Margin | % Change | |
|---|---|---|---|
| Mar2026 | 31.01 | 8.58 | |
| Mar2025 | 28.56 | 18.95 | |
| Mar2024 | 24.01 | 6.52 | |
| Mar2023 | 22.54 | 6.32 | |
| Mar2022 | 21.2 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Margin ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹41,518.2 Cr | 2.2% | 11% | -25.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 2.2% |
11% |
-25.7% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses